Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: March 11, 2023
Programmed
cell
death
ligand
1
protein-positive
(PD-L1+)
exosomes
have
been
found
to
be
a
potential
biomarker
for
the
diagnosis
of
non-small
lung
cancer
(NSCLC).
However,
development
highly
sensitive
detection
technique
PD-L1+
is
still
challenge
in
clinical
applications.
Herein,
sandwich
electrochemical
aptasensor
based
on
ternary
metal-metalloid
palladium-copper-boron
alloy
microporous
nanospheres
(PdCuB
MNs)
and
Au@CuCl2
nanowires
(NWs)
was
designed
exosomes.
The
excellent
peroxidase-like
catalytic
activity
PdCuB
MNs
high
conductivity
NWs
endow
fabricated
with
intense
signal,
thus
enabling
low
abundance
analytical
results
revealed
that
maintained
favorable
linearity
over
wide
concentration
range
6
orders
magnitude
reached
limit
36
particles/mL.
successfully
applied
analysis
complex
serum
samples
achieves
accurate
identification
NSCLC
patients.
Overall,
developed
provides
powerful
tool
early
NSCLC.
Analytical Chemistry,
Journal Year:
2023,
Volume and Issue:
95(44), P. 16029 - 16048
Published: Oct. 24, 2023
Extracellular
vesicles
(EVs)
are
crucial
mediators
of
intercellular
communication
and
can
be
classified
based
on
their
physical
properties,
biomolecular
structure,
origin.
Among
EVs,
exosomes
have
garnered
significant
attention
due
to
potential
as
therapeutic
diagnostic
tools.
Exosomes
released
via
fusion
multivesicular
bodies
plasma
membranes
isolated
from
various
biofluids
using
methods
such
differential
ultracentrifugation,
immune
affinity
capture,
ultrafiltration,
size
exclusion
chromatography.
Herein,
an
overview
different
techniques
for
exosome
characterization
isolation,
well
the
diverse
applications
detection,
including
use
in
drug
delivery
disease
diagnosis,
is
provided.
Additionally,
we
discuss
emerging
field
detection
by
sensors,
which
offers
up-and-coming
avenue
point-of-care
tools
development.
Overall,
this
review
aims
provide
a
exhaustive
up-to-date
summary
current
state
research.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(2), P. 1786 - 1786
Published: Jan. 16, 2023
The
emerging
concept
of
cancer
stem
cells
(CSCs)
as
the
key
driver
behind
carcinogenesis,
progression,
and
diversity
has
displaced
prior
model
a
tumor
composed
with
similar
subsequently
acquired
mutations
an
equivalent
capacity
for
renewal,
invasion,
metastasis.
This
significant
change
shifted
research
focus
toward
targeting
CSCs
to
eradicate
cancer.
may
be
characterized
using
cell
surface
markers.
They
are
defined
by
their
self-renew
differentiate,
resist
conventional
therapies,
generate
new
tumors
following
repeated
transplantation
in
xenografted
mice.
CSCs'
functional
capabilities
governed
various
intracellular
extracellular
variables
such
pluripotency-related
transcription
factors,
internal
signaling
pathways,
external
stimuli.
Numerous
natural
compounds
synthetic
chemicals
have
been
investigated
ability
disrupt
these
regulatory
components
inhibit
stemness
terminal
differentiation
CSCs,
hence
achieving
clinical
implications.
However,
no
treatment
focuses
on
biological
consequences
drugs
functions
established.
article
provides
biomedical
discussion
at
time
along
overview
origin,
features,
characterization,
isolation
techniques,
novel
targeted
therapeutic
approaches.
Additionally,
we
highlighted
factors
endorsed
controlling
or
helping
promote
CSCs.
Our
objective
was
encourage
future
studies
prospective
treatments
develop
framework
application
single
combined
therapeutics
forms
Biomarker Research,
Journal Year:
2023,
Volume and Issue:
11(1)
Published: Nov. 17, 2023
Abstract
While
the
field
of
precision
oncology
is
rapidly
expanding
and
more
targeted
options
are
revolutionizing
cancer
treatment
paradigms,
therapeutic
resistance
particularly
to
immunotherapy
remains
a
pressing
challenge.
This
can
be
largely
attributed
dynamic
tumor-stroma
interactions
that
continuously
alter
microenvironment.
date
most
advancements
have
been
made
through
examining
clinical
utility
tissue-based
biomarkers,
their
invasive
nature
lack
holistic
representation
evolving
disease
in
real-time
manner
could
result
suboptimal
decisions.
Thus,
using
minimally-invasive
approaches
identify
biomarkers
predict
monitor
response
as
well
alert
emergence
recurrences
critical
need.
Currently,
research
efforts
shifting
towards
developing
liquid
biopsy-based
obtained
from
patients
over
course
disease.
Liquid
biopsy
represents
unique
opportunity
intercellular
communication
within
tumor
microenvironment
which
occur
exchange
extracellular
vesicles
(EVs).
EVs
lipid
bilayer
membrane
nanoscale
transfer
plethora
biomolecules
mediate
crosstalk,
shape
microenvironment,
modify
drug
response.
The
capture
innovative
approaches,
such
microfluidics,
magnetic
beads,
aptamers,
allow
analysis
via
high
throughput
multi-omics
techniques
facilitate
use
for
biomarker
discovery.
Artificial
intelligence,
machine
deep
learning
algorithms,
advancing
analyses
uncover
candidate
predictive
signatures
key
translation
into
trials.
With
increasing
recognition
role
mediating
immune
evasion
valuable
source,
these
snapshots
cellular
promising
become
an
important
tool
spur
strategies
block
immunotherapy.
In
this
review,
we
discuss
emerging
describing
current
advances
isolation
function
mediators
We
also
highlight
recent
lung
melanoma
studies
point
application
potential
immuno-oncology.
International Journal of Nanomedicine,
Journal Year:
2023,
Volume and Issue:
Volume 18, P. 3285 - 3307
Published: June 1, 2023
Abstract:
Extracellular
vesicles
(EVs)
are
nanoscale
bilayer
phospholipid
membrane
released
by
cells.
Contained
large
molecules
such
as
nucleic
acid,
protein,
and
lipid,
EVs
an
integral
part
of
cell
communication.
The
contents
vary
based
on
the
source
play
important
role
in
both
pathological
physiological
conditions.
can
be
used
drugs
or
targets
disease
treatment,
changes
indicate
progression
diseases.
In
recent
years,
with
continuous
exploration
structure,
characteristics,
functions
EVs,
potential
engineered
for
drug
delivery
therapy
being
constantly
explored.
This
review
provides
a
brief
overview
characteristics
summarizes
advanced
application
outlook
prospect
it.
It
is
our
hope
that
this
will
increase
understanding
current
development
medical
applications
help
us
overcome
future
challenges.
Keywords:
extracellular
vesicle,
nanotherapeutic,
diagnosis,
exosome,
advances
Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: March 11, 2023
Programmed
cell
death
ligand
1
protein-positive
(PD-L1+)
exosomes
have
been
found
to
be
a
potential
biomarker
for
the
diagnosis
of
non-small
lung
cancer
(NSCLC).
However,
development
highly
sensitive
detection
technique
PD-L1+
is
still
challenge
in
clinical
applications.
Herein,
sandwich
electrochemical
aptasensor
based
on
ternary
metal-metalloid
palladium-copper-boron
alloy
microporous
nanospheres
(PdCuB
MNs)
and
Au@CuCl2
nanowires
(NWs)
was
designed
exosomes.
The
excellent
peroxidase-like
catalytic
activity
PdCuB
MNs
high
conductivity
NWs
endow
fabricated
with
intense
signal,
thus
enabling
low
abundance
analytical
results
revealed
that
maintained
favorable
linearity
over
wide
concentration
range
6
orders
magnitude
reached
limit
36
particles/mL.
successfully
applied
analysis
complex
serum
samples
achieves
accurate
identification
NSCLC
patients.
Overall,
developed
provides
powerful
tool
early
NSCLC.